Loading

Cell View

Cell Information

  PDX primary renal cell carcinoma

Overall DesignIn order to identify successful clonal propagation from patient to PDX samples and understand pathogenesis from primary to metastatic RCC, we performed whole-exome sequencing (WES, n=4) and matched aCGH (n=4) on bulk tumor samples. And we utilized single-cell RNA sequencing (scRNA-seq) to model and dissect functional heterogeneity acroass primary and metastatic RCC tumors. We checked whether of capturing live one cell, not more cells, in microfluidics by fluorescent microscopic observation. To construct RNA sequencing libraries, we performed further quality controls including adequate quantities and qualities of amplified transcriptomes respectively from single cells. Tumor cells from the parental mRCC (n=34), PDX-mRCC (n=36) and PDX-pRCC (n=46) were finally analyzed in this study after filtering out poor quality cells.
SummaryClear cell renal cell carcinoma (ccRCC) initiated from the renal epithelium is the most prevalent histological type of adult kidney cancers. Dissecting intratumoral heterogeneity (ITH) of ccRCC has leveraged to extend our knowledge on how primary tumors harboring driver mutations evolve and spread to other sites. The cellular fractions within and across the primary (pRCC) and metastatic RCC (mRCC) are heterogeneous in both their genetic and biological features determining the variability in clinical aggressiveness and sensitivity to the therapy. To achieve sustainable therapeutic benefit with targeted agents in mRCC, the effective target should focus on signaling pathways that are related to driver mutations occurred early in the clonal evolution of the disease and thus should be common to primary tumor and metastatic sites. Considering that extensive genetic heterogeneity may result in drug response variability among patients and treatment resistance, the tailored strategies for metastatic RCC is urgently needed. Here, we analyze single-cell RNA-seq (scRNA-seq) data from a matched primary RCC (pRCC) and lung metastasis (mRCC) to dissect ITH at the highest resolution to date with the objective of discovering the better therapeutic regimen.
Dataset viewGSE73121
PMID27139883

Samples in PDX primary renal cell carcinoma

Displaying 41-47 of 47 results.
SeriesSampleInstrumentOrganismTitleCell Source
GSE73121GSM1887293Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_87PDX primary renal cell carcinoma
GSE73121GSM1887294Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_88PDX primary renal cell carcinoma
GSE73121GSM1887295Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_89PDX primary renal cell carcinoma
GSE73121GSM1887296Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_90PDX primary renal cell carcinoma
GSE73121GSM1887297Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_91PDX primary renal cell carcinoma
GSE73121GSM1887299Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_93PDX primary renal cell carcinoma
GSE73121GSM1887301Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_94PDX primary renal cell carcinoma

Gene rank in PDX primary renal cell carcinoma

Displaying 41-50 of 18370 results.
Rank orderGene SymbolEnsembl ID
41RPS19ENSG00000105372
42CALM2ENSG00000143933
43RPS20ENSG00000008988
44USMG5ENSG00000173915
45PDZK1IP1ENSG00000162366
46RPL41P1ENSG00000227063
47LGALS1ENSG00000100097
48RPL36ENSG00000130255
49MYL6ENSG00000092841
50RPL30ENSG00000156482